Ledger.Open graph →
SEC Form D · filed December 1, 2021

Fountain Therapeutics, Inc

Offering
$15.9M
Sold
$15.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

William Greene · Boston, MAExec · DirectorThomas Rando · San Francisco, CAExec · DirectorAshish Khanna · Foster City, CADirectorAlex Morgan · Menlo Park, CADirectorWilliam Greene · South San Francisco, CAExec · DirectorThomas Rando · San Francisco, CAExec · DirectorAshish Khanna · Foster City, CADirectorAlex Morgan · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗